183 related articles for article (PubMed ID: 12953017)
1. 14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries.
Gauthier KM; Jagadeesh SG; Falck JR; Campbell WB
Hypertension; 2003 Oct; 42(4):555-61. PubMed ID: 12953017
[TBL] [Abstract][Full Text] [Related]
2. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries.
Gauthier KM; Deeter C; Krishna UM; Reddy YK; Bondlela M; Falck JR; Campbell WB
Circ Res; 2002 May; 90(9):1028-36. PubMed ID: 12016270
[TBL] [Abstract][Full Text] [Related]
3. 14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.
Gauthier KM; Edwards EM; Falck JR; Reddy DS; Campbell WB
Hypertension; 2005 Apr; 45(4):666-71. PubMed ID: 15699460
[TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation.
Dimitropoulou C; West L; Field MB; White RE; Reddy LM; Falck JR; Imig JD
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):50-61. PubMed ID: 17259072
[TBL] [Abstract][Full Text] [Related]
5. 11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.
Bukhari IA; Shah AJ; Gauthier KM; Walsh KA; Koduru SR; Imig JD; Falck JR; Campbell WB
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1574-83. PubMed ID: 22307677
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids.
Weston AH; Félétou M; Vanhoutte PM; Falck JR; Campbell WB; Edwards G
Br J Pharmacol; 2005 Jul; 145(6):775-84. PubMed ID: 15895105
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs.
Pratt PF; Li P; Hillard CJ; Kurian J; Campbell WB
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1113-21. PubMed ID: 11179054
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.
Gauthier KM; Baewer DV; Hittner S; Hillard CJ; Nithipatikom K; Reddy DS; Falck JR; Campbell WB
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1344-51. PubMed ID: 15528233
[TBL] [Abstract][Full Text] [Related]
9. Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation.
Yang W; Gauthier KM; Reddy LM; Sangras B; Sharma KK; Nithipatikom K; Falck JR; Campbell WB
Hypertension; 2005 Apr; 45(4):681-6. PubMed ID: 15699458
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding.
Yang W; Holmes BB; Gopal VR; Kishore RV; Sangras B; Yi XY; Falck JR; Campbell WB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1023-31. PubMed ID: 17327488
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels.
Archer SL; Gragasin FS; Wu X; Wang S; McMurtry S; Kim DH; Platonov M; Koshal A; Hashimoto K; Campbell WB; Falck JR; Michelakis ED
Circulation; 2003 Feb; 107(5):769-76. PubMed ID: 12578883
[TBL] [Abstract][Full Text] [Related]
12. Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor in bovine coronary arteries.
Campbell WB; Falck JR; Gauthier K
Med Sci Monit; 2001; 7(4):578-84. PubMed ID: 11433180
[TBL] [Abstract][Full Text] [Related]
13. 14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.
Bukhari IA; Gauthier KM; Jagadeesh SG; Sangras B; Falck JR; Campbell WB
J Pharmacol Exp Ther; 2011 Jan; 336(1):47-55. PubMed ID: 20881018
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Eckman DM; Hopkins N; McBride C; Keef KD
Br J Pharmacol; 1998 May; 124(1):181-9. PubMed ID: 9630358
[TBL] [Abstract][Full Text] [Related]
15. Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles.
Wang D; Borrego-Conde LJ; Falck JR; Sharma KK; Wilcox CS; Umans JG
Kidney Int; 2003 Jun; 63(6):2187-93. PubMed ID: 12753306
[TBL] [Abstract][Full Text] [Related]
16. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.
Gauthier KM; Falck JR; Reddy LM; Campbell WB
Pharmacol Res; 2004 Jun; 49(6):515-24. PubMed ID: 15026029
[TBL] [Abstract][Full Text] [Related]
17. Epoxyeicosatrienoic acids (EET(11,12)) may partially restore endothelium-derived hyperpolarizing factor-mediated function in coronary microarteries.
Zou W; Yang Q; Yim AP; He GW
Ann Thorac Surg; 2001 Dec; 72(6):1970-6. PubMed ID: 11789779
[TBL] [Abstract][Full Text] [Related]
18. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.
Campbell WB; Gebremedhin D; Pratt PF; Harder DR
Circ Res; 1996 Mar; 78(3):415-23. PubMed ID: 8593700
[TBL] [Abstract][Full Text] [Related]
19. 20-125Iodo-14,15-epoxyeicosa-5(Z)-enoic acid: a high-affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site.
Chen Y; Falck JR; Tuniki VR; Campbell WB
J Pharmacol Exp Ther; 2009 Dec; 331(3):1137-45. PubMed ID: 19762546
[TBL] [Abstract][Full Text] [Related]
20. Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells.
Li PL; Zhang DX; Ge ZD; Campbell WB
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1229-36. PubMed ID: 11893556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
